ADMA Biologics Challenges Short Report And Raises Questions On Reporting Risk [Yahoo! Finance]
ADMA Biologics Inc (ADMA)
Last adma biologics inc earnings: 3/12 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.admabiologics.com
Company Research
Source: Yahoo! Finance
ADMA Biologics responded to a short seller report by Culper Research, challenging the accuracy and reliability of the allegations. The company stated it is reviewing the claims and reaffirmed its commitment to transparent and accurate financial disclosures. The response aims to address potentially material accusations that could affect investor perception of NasdaqGM:ADMA. ADMA Biologics, trading under NasdaqGM:ADMA, has moved to publicly address the short seller report at a time when its share price stands at $8.29. The stock has seen sharp moves recently, with declines of 44.8% over the past week, 46.6% over the past month, and 53.6% year to date. Over a longer horizon, the company has recorded a very large 3 year return and a very large 5 year return, highlighting how volatile the stock has been for investors. For you as a shareholder or potential investor, the company's rebuttal and review of the short seller claims may be an important data point to watch. How ADMA Biolog
Show less
Read more
Impact Snapshot
Event Time:
ADMA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ADMA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ADMA alerts
High impacting ADMA Biologics Inc news events
Weekly update
A roundup of the hottest topics
ADMA
News
- ADMA Biologics, Inc. (ADMA) Crashes 16% Amid Scrutiny Over Skyrocketing Days Sales Outstanding That Short Seller Claims Points to Improper Channel Stuffing, Hagens Berman InvestigatingGlobeNewswire
- ADMA BIOLOGICS, INC. INVESTIGATION: Kirby McInerney LLP Announces Investigation Into Potential Securities FraudBusiness Wire
- ADMA INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating ADMA Biologics, Inc. on Behalf of ADMA Stockholders and Encourages Investors to Contact the FirmGlobeNewswire
- ADMA Biologics Issues Statement Refuting Unsubstantiated, Misleading and Inaccurate Allegations by Culper Research [Yahoo! Finance]Yahoo! Finance
- ADMA Biologics Issues Statement Refuting Unsubstantiated, Misleading and Inaccurate Allegations by Culper ResearchGlobeNewswire
ADMA
Earnings
- 11/5/25 - Miss
ADMA
Sec Filings
- 3/27/26 - Form 8-K
- 3/26/26 - Form SCHEDULE
- 3/17/26 - Form 4
- ADMA's page on the SEC website